Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
UTILIZATION AND COST OF SEROLOGIC TESTS FOR LYME-DISEASE IN MARYLAND
Autore:
STRICKLAND GT; KARP AC; MATHEWS A; PENA CA;
Indirizzi:
UNIV MARYLAND,SCH MED,DEPT EPIDEMIOL & PREVENT MED BALTIMORE MD 21201
Titolo Testata:
The Journal of infectious diseases
fascicolo: 3, volume: 176, anno: 1997,
pagine: 819 - 821
SICI:
0022-1899(1997)176:3<819:UACOST>2.0.ZU;2-C
Fonte:
ISI
Lingua:
ENG
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
8
Recensione:
Indirizzi per estratti:
Citazione:
G.T. Strickland et al., "UTILIZATION AND COST OF SEROLOGIC TESTS FOR LYME-DISEASE IN MARYLAND", The Journal of infectious diseases, 176(3), 1997, pp. 819-821

Abstract

To ascertain use of serologic tests for Lyme disease (LD) in Maryland, all laboratories registered with the State Health Department were surveyed. Results show that from 1992 to 1995, 17 laboratories performed100,000 serologic tests costing $7.1 million on Maryland residents; 90% of these tests were EIAs. The proportion of positive EIAs increasedfrom 3.4% in 1992 to similar to 7.0% in 1994 and 1995, and the percentage of positive second tests (Western blot, WB) fell from 7.9% to 5.0%-5.5%. The large number of EIAs performed in comparison with the low incidence of LD in the state results in a low predictive value of a positive EIA test. Therefore, the WE is Indicated to confirm equivocal and positive EIA tests when characteristic clinical findings of LD are not present. The 30,000 tests for LD performed annually on Maryland residents at a cost of over $2 million in direct medical costs must be added to the public health burden of LD in this state.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/04/20 alle ore 01:41:18